The Revolution in Real-World Evidence (RWE): Leveraging Patient-Generated Data for Accelerated Drug Development and Post-Market Surveillance
  The biopharmaceutical industry is experiencing a profound shift away from relying solely on controlled, randomized clinical trials (RCTs) towards the integration of Real-World Evidence (RWE) in drug development, regulatory decision-making, and post-market surveillance. RWE is derived from Real-World Data (RWD), which encompasses patient information gathered outside the traditional...
0 Commenti 0 condivisioni 510 Views 0 Anteprima
MTSocial https://mtsocial.ir